Neeraj Vij, MS, PhD, ATSF

Chief Executive Officer at Precision Theranostics

Neeraj Vij, MS, PhD, ATSF has held various roles in the medical field since 2006. Neeraj began their career at Johns Hopkins Medicine as Assistant Professor of Pediatrics, Pulmonary Medicine, NanoBiotechnology, and Global Health and Faculty/Instructor of Pediatrics and Pulmonary Medicine in 2006. In 2013, they moved to Central Michigan University College of Medicine as an Associate Professor of Molecular & Cell Biology and Pulmonary Medicine. In 2014, they returned to Johns Hopkins Medicine as Adjunct Associate Professor of Pediatrics and Pulmonary Medicine in the School of Medicine. In 2017, they became the Chief Executive Officer of VIJ BIOTECH. In 2018, they joined 4DMedical (formerly 4Dx) as Chief Clinical Development Officer and Senior Vice President & Program Director Clinical Development. Neeraj currently serves as Chief Executive Officer of PRECISION THERANOSTICS INC (PTNx).

Neeraj Vij, MS, PhD, ATSF completed a Postdoc at The Johns Hopkins University School of Medicine from 2002 to 2006, studying Molecular & Cell Biology and Pulmonary Medicine. Neeraj then obtained a Diploma from the Institute of Genetics, Biological Research Centre of Hungarian Academy of Sciences and Centre of Excellence of The European Union in 2000-2001, studying Microbial Genetics and Techniques in Modern Biology. From 2001 to 2002, Neeraj Vij completed a Postdoctoral Research Scientist position in Dermatology at Heidelberg University, studying Molecular Biology & Immunology. In 2019, they obtained a DRUG AND MEDICAL DEVICE DEVELOPMENT certification from the Massachusetts Institute of Technology, with a STRATEGIC APPROACH. Neeraj is currently pursuing a Doctor of Philosophy (PhD) in Biosciences & Biotechnology at the Indian Institute of Technology, Roorkee.

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Precision Theranostics

Precision Theranostics (PTNx) is committed to bringing the next-generation solutions for treatment and early diagnosis of chronic and fatal diseases.


Industries

Employees

1-10

Links